HAVN Life Sciences Inc

5NP0

Company Profile

  • Business description

    HAVN Life Sciences Inc is a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of APIs, the development of natural health products, and innovative therapies to support brain health and enhance the capabilities of the mind. Through its research division, HAVN Labs, the company has developed an end-to-end supply chain of standardized, naturally derived psychedelic compounds for research that will define the future of modern medicine. With its new line of natural health products, it offers a full range of high-quality mushroom and plant extracts that help boost immune function, reduce inflammation and support a healthy lifestyle.

  • Contact

    605 - 130 Brew Street
    Port MoodyBCV3H 0E3
    CAN

    T: +1 604 639-2143

    https://www.havnlife.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 April 2026

    Employees

    6

Stocks News & Analysis

stocks

Lower fair value on ASX best idea

Shares are still undervalued despite drop in profit margins.
stocks

We raise our near-term gold price assumptions

Our coverage remains overvalued.
stocks

Apple: Gemini partnership lets AI-worried investors breathe a sigh of relief

We believe a competitive—if not leading—AI feature suite will reinforce Apple’s wide-moat mobile device ecosystem.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,161.5050.00-0.54%
CAC 408,330.9716.23-0.19%
DAX 4025,286.24134.42-0.53%
Dow JONES (US)49,149.6342.36-0.09%
FTSE 10010,184.3547.000.46%
HKSE26,882.22117.59-0.44%
NASDAQ23,471.75238.13-1.00%
Nikkei 22553,785.25555.98-1.02%
NZX 50 Index13,659.5298.19-0.71%
S&P 5006,926.6037.14-0.53%
S&P/ASX 2008,837.3043.70-0.49%
SSE Composite Index4,101.5224.57-0.60%

Market Movers